Ohki Healthcare Holdings Co.,Ltd. (TYO:3417)
Japan · Delayed Price · Currency is JPY 1,430.00
+2.00 (0.14%)
Jan 23, 2026, 3:30 PM JST
Ohki Healthcare Holdings Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 357,174 | 349,452 | 334,661 | 304,445 | 278,162 | 286,173 | Upgrade | |
Revenue Growth (YoY) | 4.30% | 4.42% | 9.93% | 9.45% | -2.80% | 3.21% | Upgrade |
Cost of Revenue | 337,806 | 330,942 | 317,460 | 288,563 | 264,437 | 256,584 | Upgrade |
Gross Profit | 19,368 | 18,510 | 17,201 | 15,882 | 13,725 | 29,589 | Upgrade |
Selling, General & Admin | 15,889 | 15,408 | 14,811 | 13,496 | 12,745 | 26,185 | Upgrade |
Research & Development | 19 | 19 | 24 | 24 | 42 | 67 | Upgrade |
Operating Expenses | 16,222 | 15,741 | 15,157 | 13,822 | 13,093 | 26,579 | Upgrade |
Operating Income | 3,146 | 2,769 | 2,044 | 2,060 | 632 | 3,010 | Upgrade |
Interest Expense | -113 | -71 | -35 | -33 | -36 | -40 | Upgrade |
Interest & Investment Income | 246 | 222 | 203 | 183 | 185 | 309 | Upgrade |
Other Non Operating Income (Expenses) | 1,118 | 1,070 | 1,047 | 943 | 803 | 827 | Upgrade |
EBT Excluding Unusual Items | 4,397 | 3,990 | 3,259 | 3,153 | 1,584 | 4,106 | Upgrade |
Gain (Loss) on Sale of Investments | 13 | 13 | 3 | 24 | - | 100 | Upgrade |
Gain (Loss) on Sale of Assets | 2 | - | -63 | - | - | - | Upgrade |
Asset Writedown | -5 | -5 | - | - | - | -1 | Upgrade |
Other Unusual Items | -244 | -167 | 206 | 4 | -52 | -82 | Upgrade |
Pretax Income | 4,163 | 3,831 | 3,405 | 3,181 | 1,532 | 4,123 | Upgrade |
Income Tax Expense | 1,331 | 1,188 | 1,278 | 998 | 605 | 1,231 | Upgrade |
Earnings From Continuing Operations | 2,832 | 2,643 | 2,127 | 2,183 | 927 | 2,892 | Upgrade |
Minority Interest in Earnings | -1 | -4 | 83 | -1 | 45 | -96 | Upgrade |
Net Income | 2,831 | 2,639 | 2,210 | 2,182 | 972 | 2,796 | Upgrade |
Net Income to Common | 2,831 | 2,639 | 2,210 | 2,182 | 972 | 2,796 | Upgrade |
Net Income Growth | 51.80% | 19.41% | 1.28% | 124.49% | -65.24% | 18.17% | Upgrade |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 14 | Upgrade |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 14 | Upgrade |
Shares Change (YoY) | -0.43% | -0.97% | -0.12% | - | -0.00% | -0.52% | Upgrade |
EPS (Basic) | 207.53 | 193.46 | 160.43 | 158.21 | 70.48 | 202.73 | Upgrade |
EPS (Diluted) | 207.53 | 193.46 | 160.43 | 158.21 | 70.48 | 202.73 | Upgrade |
EPS Growth | 52.45% | 20.59% | 1.40% | 124.49% | -65.24% | 18.79% | Upgrade |
Free Cash Flow | -1,479 | -12,026 | 7,271 | -138 | 1,218 | -4,401 | Upgrade |
Free Cash Flow Per Share | -108.42 | -881.58 | 527.82 | -10.01 | 88.31 | -319.11 | Upgrade |
Dividend Per Share | 26.000 | 26.000 | 24.000 | 22.000 | 21.000 | 20.000 | Upgrade |
Dividend Growth | 8.33% | 8.33% | 9.09% | 4.76% | 5.00% | 5.26% | Upgrade |
Gross Margin | 5.42% | 5.30% | 5.14% | 5.22% | 4.93% | 10.34% | Upgrade |
Operating Margin | 0.88% | 0.79% | 0.61% | 0.68% | 0.23% | 1.05% | Upgrade |
Profit Margin | 0.79% | 0.76% | 0.66% | 0.72% | 0.35% | 0.98% | Upgrade |
Free Cash Flow Margin | -0.41% | -3.44% | 2.17% | -0.04% | 0.44% | -1.54% | Upgrade |
EBITDA | 3,535 | 3,156 | 2,421 | 2,435 | 1,013 | 3,406 | Upgrade |
EBITDA Margin | 0.99% | 0.90% | 0.72% | 0.80% | 0.36% | 1.19% | Upgrade |
D&A For EBITDA | 389 | 387 | 377 | 375 | 381 | 396 | Upgrade |
EBIT | 3,146 | 2,769 | 2,044 | 2,060 | 632 | 3,010 | Upgrade |
EBIT Margin | 0.88% | 0.79% | 0.61% | 0.68% | 0.23% | 1.05% | Upgrade |
Effective Tax Rate | 31.97% | 31.01% | 37.53% | 31.37% | 39.49% | 29.86% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.